Bruker (BRKR) Cash from Investing Activities (2010 - 2026)
Bruker's (BRKR) quarterly Cash from Investing Activities came in at -$39.7 million in Q1 2026, down 52.11% YoY from -$82.9 million in Q1 2025, and up 28.47% on a QoQ basis from -$55.5 million in Q4 2025.
Bruker (BRKR) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Cash from Investing Activities data on file, last reported at -$39.7 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 52.11% year-over-year to -$39.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210.1 million (up 85.8% YoY) and the FY2025 annual result came in at -$196.5 million, up 88.82% from the prior year.
- Cash from Investing Activities advanced to -$39.7 million in Q1 2026, from -$55.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $57.1 million in Q2 2022 to a low of -$1.3 billion in Q2 2024.
- A 5-year average of -$151.2 million and a median of -$60.6 million in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 179.97% — and 2024, when it sank 4995.77%.
- Tracing BRKR's Cash from Investing Activities over 5 years: stood at -$149.3 million in 2022, then jumped by 75.35% to -$36.8 million in 2023, then tumbled by 64.67% to -$60.6 million in 2024, then climbed by 8.42% to -$55.5 million in 2025, then grew by 28.47% to -$39.7 million in 2026.
- The last three Cash from Investing Activities figures came in at -$39.7 million (Q1 2026), -$55.5 million (Q4 2025), and -$23.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Bruker | 9.13 Bn | 9.13 Bn | 416.00 Mn | -25.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.30 Mn |
| Jun 30, 2026 | -25.30 Mn |
| Mar 31, 2026 | -39.70 Mn |
| Mar 31, 2026 | -39.70 Mn |
| Dec 31, 2025 | -55.50 Mn |
| Dec 31, 2025 | -55.50 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | -91.10 Mn |
| Jun 30, 2025 | -91.10 Mn |
| Mar 31, 2025 | -26.10 Mn |
| Mar 31, 2025 | -26.10 Mn |
| Dec 31, 2024 | -60.60 Mn |
| Dec 31, 2024 | -60.60 Mn |
| Sep 30, 2024 | -67.60 Mn |
| Sep 30, 2024 | -67.60 Mn |
| Jun 30, 2024 | -1.32 Bn |
| Jun 30, 2024 | -1.32 Bn |
| Mar 31, 2024 | -304.20 Mn |
| Mar 31, 2024 | -304.20 Mn |